January 09, 2023
Article
Custom is one of the growing number of companies focusing on adherence. It changed its name from Pack4U last year.
December 27, 2022
According to the company, clinical outcomes for 78 dry eye patients treated at a single center, the Cleveland Eye Clinic, showcased the duration of efficacy of a single, first-time treatment of MGD using the TearCare System.
December 22, 2022
Eli Lilly and Company and Boehringer Ingelheim announced their SGLT2 inhibitor, empagliflozin, was associated with statistically significant reductions in HbA1c relative to placebo therapy among a population of pediatric patients with type 2 diabetes in the DINAMO trial.
December 06, 2022
A new analysis suggests those with an increased body mass index and women were more likely to experience long COVID
November 29, 2022
New research adds more evidence of Black patients facing disparities in diabetes care.
November 24, 2022
European research examines antibiotic exposure and its potential impact on future type 2 diabetes risk.